There was no significant difference between the five dimensions of the MFI, or the eight scales of the SF36 between PR3- and MPO-AAV-CFS patients (data not shown). This evidence concerns the gene PRTN3 and myalgic encephalomeyelitis/chronic fatigue syndrome.